Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.
Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis.
Neurofascin antibodies in inflammatory neuropathy: How many needles make a haystack?
Natalizumab: Bench to Bedside and Beyond.
Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord.
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS.
The relationship between muscle pain and fatigue.
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
Adapted exercise interventions for persons with progressive multiple sclerosis.
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund's Adjuvant in Three Non-human Primate Species.
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Pages
« first
‹ previous
…
426
427
428
429
430
431
432
433
434
…
next ›
last »